These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7783258)

  • 21. Neuron-specific enolase as a marker for medulloblastoma.
    Plowman PN
    Lancet; 1990 Dec; 336(8727):1388. PubMed ID: 1978205
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuron-specific enolase: how useful as a cancer marker?
    Carney DN; Teeling M
    Eur J Cancer Clin Oncol; 1988 May; 24(5):825-8. PubMed ID: 3049114
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Egberts F; Hitschler WN; Weichenthal M; Hauschild A
    Melanoma Res; 2009 Feb; 19(1):31-5. PubMed ID: 19104452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
    Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
    Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.
    Alm El-Din MA; Farouk G; Nagy H; Abd Elzaher A; Abo El-Magd GH
    Int J Biol Markers; 2012 Jul; 27(2):e139-46. PubMed ID: 22467097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum gamma-enolase as a marker for renal cell carcinoma].
    Takashi M; Tanaka J; Mitsuya H; Murase T; Haimoto H; Kato K
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):220-6. PubMed ID: 3225998
    [No Abstract]   [Full Text] [Related]  

  • 29. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enolase isoenzymes as diagnostic markers.
    Royds JA; Taylor CB; Timperley WR
    Neuropathol Appl Neurobiol; 1985; 11(1):1-16. PubMed ID: 2860580
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuron-specific enolase concentrations in serum in nonneoplastic patients with pneumonia.
    Collazos J; Esteban C; Fernández A
    Clin Chem; 1994 Feb; 40(2):266-7. PubMed ID: 8313605
    [No Abstract]   [Full Text] [Related]  

  • 32. Pediatric ovarian dysgerminoma with highly elevated serum neuron-specific enolase.
    Hayase T; Matsubara D; Maeda K; Aihara T; Morimoto A
    Pediatr Int; 2018 Oct; 60(10):982-983. PubMed ID: 30345703
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
    Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enolase isoenzymes in benign and malignant melanocytic lesions.
    Royds JA; Parsons MA; Rennie IG; Timperley WR; Taylor CB
    Diagn Histopathol; 1982; 5(3):175-81. PubMed ID: 6183083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
    Dittadi R; Gion M
    Clin Biochem; 2013 Aug; 46(12):1145. PubMed ID: 23608355
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastoma.
    Dhillon AP; Rode J; Leathem A
    Histopathology; 1982 Jan; 6(1):81-92. PubMed ID: 6120137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma.
    Schadendorf D; Zuberbier T; Diehl S; Schadendorf C; Czarnetzki BM
    Melanoma Res; 1995 Oct; 5(5):351-3. PubMed ID: 8541726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung.
    Güner G; Oktay G; Akkoçlu A; Karlikaya C
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):306S. PubMed ID: 8224452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.